OMOriol Martin-Segarra

Oriol Martin-Segarra

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Oriol Martin-Segarra has a total of 19 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Real-world experience of barriers to diagnosis, early detection and disease management among migrants living with HIV in Spain: a qualitative study

    by María Belén Martín-Sanz, Oriol Martin-Segarra, Domingo Palacios-Ceña, Antonio Gil-Crujera, Stella Maris Gómez-Sánchez, María Velasco-Arribas

    To describe the barriers and challenges in the medical care management of a group of migrants living with HIV who received medical assistance through the Spanish Public Health Care Services. A qualitative descriptive study was conducted. The inclusion criteria comprised patients with a confirmed serological diagnosis of HIV whose countries of origin were in Latin America, the Caribbean, Africa, or Eastern Europe. A total of 21 patients were selected through purposive sampling. Data collection involved in-depth interviews and researcher field notes. A thematic analysis was performed, and trustworthiness criteria were applied. Two themes were identified that illustrate the barriers to healthcare in migrants living with HIV: a) Personal beliefs and the social and family environment, participants often remain in contact with members of their culture and/or ethnic group of origin, and their environment can hinder help-seeking, treatment adherence, or open communication about their illness; b) The healthcare environment, where obstacles and challenges faced by participants are described in relation to the healthcare environment, the healthcare system, and healthcare providers. The results of this study provide a foundation for developing a roadmap of relevant patient-reported outcomes in HIV care. These insights can guide the implementation of improved healthcare strategies for migrants living with HIV.


  • Integration of beta‐lactam allergy evaluation in a Spanish antibiotic stewardship programme

    by Leonor Moreno‐Nuñez, Ana Rosado‐Ingelmo, Ana González‐Moreno, Oriol Martín‐Segarra, Rafael Hervás‐Gómez, Sira Sanz‐Márquez, Elia Pérez‐Fernández, Juan‐Emilio Losa‐García, Miguel‐Angel Tejedor‐Alonso


  • Fulminant Emphysematous Pyelonephritis by Candida glabrata in a Kidney Allograft

    by Clara Cases-Corona, Amir Shabaka, Andrea Gonzalez-Lopez, Oriol Martin-Segarra, Maria Angeles Moreno de la Higuera, Rafael Lucena, Gema Fernandez-Juarez

    Emphysematous pyelonephritis (EPN) is a rare and serious necrotizing infection that is potentially life-threatening. It has been seldom reported in kidney grafts and is usually caused by Gram-negative bacteria, with some case reports caused by anaerobic bacteria, and has been closely associated with poorly controlled diabetes mellitus (DM) and urinary tract structural abnormalities. There are no reports of EPN of fungal etiology in kidney grafts. We present a case of a 53-year-old kidney transplant recipient with a history of DM, active vesicoureteral reflux, and recurrent urinary tract infections who developed EPN in the kidney allograft caused by Candida glabrata, 3 weeks after starting treatment with empagliflozin, with an aggressive course that required urgent transplant nephrectomy.